The role of IL-33 in immunotherapy for breast cancer: targets and signalling pathways
European Cytokine Network · 2025
DOI: 10.1684/ecn.2025.0500 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Cytokine Network, 2025. Verfasst von Fu Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The People's Hospital of Yuhuan, Taizhou 317600, Zhejiang Province, China, Department of General Surgery, The First Af…. Hauptthemen laut MEDLINE: Interleukin-33, Breast Neoplasms, Signal Transduction, Immunotherapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The People's Hospital of Yuhuan, Taizhou 317600, Zhejiang Province, China, Department of General Surgery, The First Affiliated Hospital of Wenzhou Medical University (Yuhuan Branch), Taizh…
- Department of Surgery, Second Affiliated Hospital of School of Medicine, Zhejiang University, Hangzhou 310009, China.
Zitieren
APA
Zhang, F., Lin, M., Jiang, Y., & Zhou, F. (2025). The role of IL-33 in immunotherapy for breast cancer: targets and signalling pathways. European Cytokine Network. https://doi.org/10.1684/ecn.2025.0500
Vancouver
Zhang F, Lin M, Jiang Y, Zhou F. The role of IL-33 in immunotherapy for breast cancer: targets and signalling pathways. European Cytokine Network. 2025. doi:10.1684/ecn.2025.0500
BibTeX
@article{Zhang2025,
author = {Zhang, Fu and Lin, Miao and Jiang, Yuancong and Zhou, Fangjian},
title = {The role of IL-33 in immunotherapy for breast cancer: targets and signalling pathways},
journal = {European Cytokine Network},
year = {2025},
doi = {10.1684/ecn.2025.0500}
}
EUVIMED